$ACHN Company News U.S. stock futures sink on shutdown

New Post Public Reply Private Reply Replies (0) Message Board

Jan 14, 2014 at 11:43 AM

$ACHN Company News

U.S. stock futures sink on shutdown fears 7:38 a.m. Sept. 30, 2013 - Barbara Kollmeyer
Zynga shares rise, Achillion drops after hours 4:51 p.m. July 1, 2013 - Wallace Witkowski
FDA puts Achillion Hep C drug on clinical hold 4:16 p.m. July 1, 2013 - MarketWatch.com
Five stocks making moves 2:12 p.m. Feb. 14, 2013 - The Trading Deck
Thursday’s top gaining & declining stocks 4:02 p.m. Sept. 27, 2012 - Greg Morcroft
Achillion sees progress in hepatitis C study 8:04 a.m. Sept. 27, 2012 - MarketWatch.com
Vertex to advance testing of oral HCV drug regimen 9:34 a.m. Sept. 25, 2012 - Val Brickates Kennedy
Wednesday’s biggest gaining and declining stocks 3:37 p.m. Sept. 19, 2012 - MarketWatch
Achillion, Idenix move on price target changes 9:29 a.m. Sept. 19, 2012 - Val Brickates Kennedy
Gilead boosted as analysts hike price targets 9:42 a.m. Sept. 17, 2012 - Val Brickates Kennedy
Thursday’s biggest gaining and declining stocks 3:47 p.m. Aug. 16, 2012 - MarketWatch
Idenix plunges 30% on HCV drug setback 11:56 a.m. Aug. 16, 2012 - Val Brickates Kennedy
Bristol’s bad news is good for rivals: analysts 4:52 p.m. Aug. 2, 2012 - Val Brickates Kennedy
Gilead shares boosted by Bristol-Myers drug news 10:24 a.m. Aug. 2, 2012 - Val Brickates Kennedy
Bristol-Myers falls 7% on hepatitis C drug setback 9:09 a.m. Aug. 2, 2012 - Val Brickates Kennedy
Stocks to watch Thursday: Annie’s, Rite Aid 4:02 p.m. June 6, 2012 - David B. Wilkerson
Achillion's chief medical officer resigns 3:19 p.m. June 6, 2012 - Val Brickates Kennedy
Monday’s biggest gaining and declining stocks 3:23 p.m. May 21, 2012 - MarketWatch
Achillion jumps on hepatitis C study 2:22 p.m. May 21, 2012 - Val Brickates Kennedy
Thursday’s biggest gaining and declining stocks 4:26 p.m. April 19, 2012 - MarketWatch

Achillion Reports HCV Pipeline Progress and Outlines 2014 HCV Milestones 5:27 a.m. Jan. 13, 2014 - benzinga.com
Achillion Pharmaceuticals (ACHN) Surges: Stock Moves 13.3% Higher - Tale of the Tape 9:04 a.m. Jan. 9, 2014 - Zacks.com
Patients Enrolled in Synageva Study - Analyst Blog 4:15 p.m. Jan. 7, 2014 - Zacks.com
Exelixis (EXEL) Jumps: Stock Moves 11.1% Higher - Tale of the Tape 9:25 a.m. Jan. 7, 2014 - Zacks.com
Athersys (ATHX) in Focus: Stock Moves 6.3% Higher - Tale of the Tape 9:04 a.m. Jan. 7, 2014 - Zacks.com
AxoGen (AXGN) in Focus: Stock Surges 25.0% - Tale of the Tape 9:46 a.m. Jan. 2, 2014 - Zacks.com
Commit To Buy Achillion Pharmaceuticals At $2.50, Earn 24% Using Options 11:08 a.m. Dec. 31, 2013 - TheStreet.com
The Young And Restless Portfolio Update: Heading Into 2014 After A Fabulous 2013 10:07 a.m. Dec. 31, 2013 - Seeking Alpha
Top Insider Trades: SIGM, GBDC, ADC, ACHN 5:05 p.m. Dec. 25, 2013 - TheStreet.com
Good Luck Chasing Celldex 6:00 a.m. Dec. 18, 2013 - TheStreet.com
Agenus (AGEN) Soars: Stock Adds 12.7% in Session - Tale of the Tape 9:04 a.m. Dec. 17, 2013 - Zacks.com
Can Achillion Pharmaceuticals (ACHN) Continue to Surge? - Tale of the Tape 8:55 a.m. Dec. 12, 2013 - Zacks.com
Achillion Pharmaceuticals' CEO Presents at Oppenheimer 24th Annual Healthcare Conference Transcript 6:19 p.m. Dec. 11, 2013 - Seeking Alpha
7 Biotechnology Stocks to Sell Now 4:00 a.m. Dec. 11, 2013 - InvestorPlace.com
Bad News Biotechs Of 2013 7:00 a.m. Dec. 10, 2013 - Seeking Alpha
Achillion Pharmaceuticals, Inc. (ACHN) Shares March Higher, Can It Continue? - Tale of the Tape 7:41 a.m. Dec. 5, 2013 - Zacks.com
Achillion Pharmaceuticals' CEO Presents at 25th Annual Piper Jaffray Healthcare Conference (Transcript) 6:30 p.m. Dec. 4, 2013 - Seeking Alpha
BioDelivery Sciences (BDSI) in Focus: Stock Adds 10.9% in Session - Tale of the Tape 8:37 a.m. Dec. 4, 2013 - Zacks.com
7 Biotechnology Stocks to Sell Now 5:15 a.m. Dec. 4, 2013 - InvestorPlace.com
Benzinga's Top #PreMarket Gainers 7:38 a.m. Dec. 2, 2013 - benzinga.com

Stock Price Movements, FDA Applications, Appointments, and Clinical Study Updates - Research Report on Alere, ARCA, Achillion, Idenix Pharmaceuticals, and Receptos 8:00 a.m. Jan. 13, 2014 - PR Newswire - PRF
Achillion Reports HCV Pipeline Progress and Outlines 2014 HCV Milestones 6:25 a.m. Jan. 13, 2014 - GlobeNewswire
ACHILLION PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Achillion Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 -- ACHN 11:53 a.m. Dec. 6, 2013 - PR Newswire
Increased Quarterly Dividends, HIV Elimination Efforts, Advanced Treatment Options, and Conference Participations - Research Report on Merck, Varian, Mylan, Achillion, and Abiomed 8:00 a.m. Dec. 4, 2013 - PR Newswire
ACHN, CTIC, DRYS and FREE added to NASDAQ Active Stock Watch List at GSR 10:01 a.m. Dec. 2, 2013 - ACCESSWIRE
Achillion to Present at the Three Upcoming Healthcare Conferences 4:05 p.m. Nov. 26, 2013 - GlobeNewswire
ACHILLION PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Achillion Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 1:21 p.m. Nov. 22, 2013 - BusinessWire
SAREHOLDER ALERT: Pomerantz Law Firm has filed a Class Action Against Achillion Pharmaceutical, Inc. and Certain Officers - ACLN 8:00 a.m. Nov. 22, 2013 - PR Newswire
Quarterly Reports and Events - Research Report on Mettler-Toledo, Galena Biopharma, Achillion, Wright Medical, and OXiGENE 8:00 a.m. Nov. 15, 2013 - PR Newswire
ACHILLION PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Achillion Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 -- ACHN 3:58 p.m. Nov. 13, 2013 - GlobeNewswire
Achillion Reiterates HCV Pipeline Priorities and Reports Third Quarter and Nine Month 2013 Financial Results 6:05 a.m. Nov. 12, 2013 - GlobeNewswire
Achillion to Present at the Credit Suisse Healthcare Conference 4:05 p.m. Nov. 11, 2013 - GlobeNewswire
SHAREHOLDER ALERT: Investors with More Than $150,000 in Losses from Investments in Achillion Pharmaceuticals, Inc. Are Encouraged to Contact Wolf Haldenstein before the December 9, 2013 Lead Plaintiff Deadline 12:38 p.m. Nov. 7, 2013 - BusinessWire
Achillion's Uridine-Analog Nucleotide Prodrug, ACH-3422, Shows Compelling Preclinical Profile 8:05 a.m. Nov. 2, 2013 - GlobeNewswire
Zeldes Haeggquist & Eck, LLP Announces Investigation of Achillion Pharmaceuticals, Inc. 8:01 a.m. Oct. 31, 2013 - BusinessWire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Achillion Pharmaceutical, Inc. of Class Action Lawsuit and Upcoming Deadline -- ACLN 1:54 p.m. Oct. 25, 2013 - GlobeNewswire
ACHILLION PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Achillion Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 -- ACHN 10:40 a.m. Oct. 25, 2013 - GlobeNewswire
Wolf Haldenstein Adler Freeman & Herz LLP Commences Class Action Lawsuit on Behalf of Achillion Pharmaceuticals, Inc. Investors 3:12 p.m. Oct. 24, 2013 - BusinessWire
Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Achillion Pharmaceuticals, Inc. 11:05 a.m. Oct. 17, 2013 - PR Newswire
AGNC, ACHN, MNKD and ACAD added to NASDAQ Active Stock Watch List at EPR 8:24 a.m. Oct. 15, 2013 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bernard Lancaster Steps Up as Mammoth's New President

A New Era Under Bernard Lancaster at Mammoth Change is in the air for Mammoth Energy Services, as Bernard “Bernie” Lancaster takes the helm as President. His promotion on November 9, 2026, might not send shockwaves through Wall Street right away, but anyone holding an interest in NASDAQ:TUSK should take note. Lancaster's appointment is the kind of decision that...

Nuix Names Lori Cornmesser to Head Global Partnerships

Nuix Shakes Things Up with New Leadership Nuix, a notable player in the investigative analytics and intelligence software space, just leveled up its game by bringing in Lori Cornmesser as the Global Vice President, Partner Ecosystems. This ain't your average hire. Cornmesser's been around the block—over 25 years, in fact—building and leading partner ecosystems...

Global Case Studies in Poverty Reduction Spotlighted

A Fresh Spotlight on Poverty Reduction Efforts Amid the clamor of social and economic challenges, 126 stellar case studies of poverty reduction just took center stage at a seminar in Beijing. These admired initiatives emerged from the seventh global solicitation, chosen from a pile of 890 entries submitted by do-gooders and organizations spanning 31 countries. If you've...

MGS Extends Engagement for BECI Power Line Project

The power game isn't always about flipping switches, my friends. With Midcontinent Grid Solutions (MGS), we're seeing another round of crowd-pleasing playacting as they pump the brakes on the BECI Project. New timeline, new promises—same old story. Investors, environmentalists, and citizens alike are watching this one unfold with a glass of iced tea and crossed fingers....

FF EAI Robotics Aims for Top Spot in K-12 Tech

FFR's Shot at Robotics Education Dominance You ever feel like a company is throwing everything but the kitchen sink at an opportunity? That's FF EAI Robotics for you—charging ahead with a hefty laundry list of tech ambitions. They've clocked in about $2.3 million in revenue from their newly acquired robotics wing for the first nine months of 2026, showing a 26% gross...

Maritime Launch's Bold Q3 Surge Amid Space Race

Rockets, Revenue, and a Bold New Path You ever hear about a spaceport tucked away in the toes of Nova Scotia, making waves with its third-quarter earnings? Well, that's exactly what's cooking over at Maritime Launch Services. These folks have managed to turn a zero into hero in a flash, reporting $5.6 million in revenue and a snug $3.5 million in net income for Q3 2026....

Etavopivat Aims to Tackle Sickle Cell Crisis Head-On

Diving headfirst into the world of sickle cell disease, Novo Nordisk has just thrown its hat in the ring with etavopivat. Now, anyone who's been following the biotech dance knows this ain't no small feat. This investigational therapy is poised to shake things up, offering a new lifeline for those wrestling with this debilitating condition. And leaping from the Phase 3...

MJ Cultivate: A New Stage for Cannabis Pioneers

Spotlight on Cannabis Innovators Look, anyone with skin in the game knows the cannabis industry is more than just shimmering stores and glossy products. It's got deep roots, and those roots grow from the hands of folks tirelessly working the soil, engineering extracts, and perfecting every last breath of a bud. That's who Jage Media's latest brainchild, MJ Cultivate,...

YYForce Expands in UAE with Key Hospitality Wins

Unveiling YYForce's Middle East Strategy Smack in the middle of an aggressive Middle Eastern expansion, YYForce (NASDAQ: YFOR) is making waves with some new headline-grabbing contracts in the UAE. This ain't just a side hustle—it's big time. They're planting their flag across the luxury hospitality sector like they're going for a moon landing. The recent announcement...

Miami Gala Raises $200K for Teen Emotional Health

A Night of Giving and Growth in Miami Ever felt like a single evening could change the world? Well, that's exactly what happened on November 7th at the Britto Palace in Miami. The Ismael Cala Foundation pulled off a remarkable feat, raising over $200,000 to boost emotional intelligence among teens through its annual gala, Legacy of Light: A Night of Joyful Giving. The...